(2E,4E,6E,8E,10E)-4,9-Dimethyldodeca-2,4,6,8,10-pentaene-1,12-diol, 97%, 1g

(R)-4-Benzhydryloxazolidin-2-one, 97%, 1g

Nitrate de mercure(II) monohydraté, min 98 %, pa, ACS, 250 g, emballage plastique.

3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, hydrochloride (1:1), (3R)-, 98%, 250mg

N,N-diméthylformamide D7, 99,5 at%D, 5 ml, conditionnement en verre

Acrylic anhydride (stabilised with 10% 4-Methoxyphenol), 90.0%, 25g

(2E)-1-(4-ethoxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

4-Amino-3-chloro-5-methylbenzonitrile, 97.0%, 25g

5-Chlorothiophene-3-carbonitrile, 95.0%, 250mg

(3-Chloro-4-(cyclopropylcarbamoyl)phenyl)boronic acid, 95.0%, 25g

5-BROMOPYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE, 95.0%, 5g

Embouts distributeurs Embouts PD // Standard, 50 ml, 1000-5000 µl, 25 pièces

N-(tert-Butoxycarbonyl)-D-2-phenylglycine>98.0%(HPLC)(T)1g